•  
  •  
 

Authors

Faris Abushamma, 1 Department of Medicine, College of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine. 2 Department of Urology, An-Najah National University Hospital, Nablus, Palestine.Follow
Amir Aghbar, 1 Department of Medicine, College of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine. 2 Department of Urology, An-Najah National University Hospital, Nablus, Palestine.Follow
Zainab E. Douglass, Department of Medicine, College of Medicine and Health Sciences, An-Najah National University, Nablus 44839, PalestineFollow
Anas Jaber, Department of Medicine, College of Medicine and Health Sciences, An-Najah National University, Nablus 44839, PalestineFollow
Enas Zidan, Department of Medicine, College of Medicine and Health Sciences, An-Najah National University, Nablus 44839, PalestineFollow
Zaher Nazzal, Department of Medicine, College of Medicine and Health Sciences, An-Najah National University, Nablus 44839, PalestineFollow
Zakaria Hamdan, 1 Department of Medicine, College of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine. 3 Department of Nephrology, An-Najah National University Hospital, Nablus, Palestine.Follow
Mahfouz Ktaifan, Department of Medicine, College of Medicine and Health Sciences, An-Najah National University, Nablus 44839, PalestineFollow
Rola Abu Alwafa, Department of Medicine, College of Medicine and Health Sciences, An-Najah National University, Nablus 44839, PalestineFollow
Hashim Hashim, Bristol Urological Institute, North Bristol NHS Trust, Bristol, United KingdomFollow

Abstract

Introduction: Lower urinary tract symptoms (LUTS) are prevalent globally. Limited research has explored LUTS in hemodialysis (HD) patients, who often experience diminished quality of life (QoL). This study aims to evaluate LUTS among female HD patients, with assessment of the symptom, risk factors, and impact on QoL. Methods: A prospective, cross-sectional study was conducted among 94 female HD patients, assessing demographics, clinical data, and LUTS using the Bristol Female Lower Urinary Tract Symptoms (BFLUTS) questionnaire. Statistical analysis examined correlations between BFLUTS, demographics, and QoL. Results: Among the study population, 91.5% of female HD patients experienced at least one filling symptom, with the most common being nocturia (65%, n = 61). Voiding symptoms were observed in 63% of participants, with hesitancy (49%, n = 46), straining (33%, n = 31), and intermittency (45%, n = 42) being notable. Incontinence symptoms were prevalent, with urgency incontinence reported by 23% of participants (n = 22). Statistically significant correlations were found between the duration of dialysis and voiding symptoms (r = 0.240, p = 0.021), as well as between poor QoL and storage symptoms (r = 0.212, p = 0.040) and incontinence symptoms (r = 0.439, p < 0.001). Additionally, significant associations were found between the presence of incontinence symptoms and diabetes mellitus (p = 0.002) and smoking (p = 0.042). Conclusion: The impact of LUTS on females undergoing HD is prevalent and should be considered as disabling syndrome. The QoL in such cohort of patients is also affected. Thus, screening protocols should be put in place to address such problem.

Share

COinS